Pulmo BioTech Inc.

About Us:

 

Pulmo BioTech Inc is a public company bringing innovative and exciting medical diagnostic technologies to the marketplace. The company’s shares are dual listed on the OTC in the US under the symbol PLMO.PK and on the Open market in Frankfurt under the symbol PBO.F

 

Our main Product Candidate is a Pulmonary Vascular molecular imaging agent called PulmoBind. We estimate that the addressable annual market for PulmoBind is in excess of $1 billion.

 

Combining business experience and the highest academic and medical credentials, our staff are proven performers in small and large firms and have worked with a broad range of investment institutions.

 

Our partners are the prestigious Montreal Heart Institute (MHI) which funded the early stage work for this exciting new diagnostic technique and Dr Jocelyn Dupuis, the originator of this new technology.

 

By bringing together the experience, imagination and drive of the inventor, the experience and facilities of the Montreal Heart Institute, and the managerial and financial capabilities of Pulmo BioTech, we believe that we will have a product capable of capturing a dominant position within our addressable market.

 

 

About our Partners

 

The Montreal Heart Institute (MHI)

 

MHI researchers have contributed towards numerous significant developments in cardiovascular research. The tradition of research at the Institute dates back to its foundation in 1954.

 

World Premieres achieved at the MHI:

 

• 1st intramyocardial implantation of the internal mammary artery, which preceded the development of aortocoronary bypasses (1955)
• 1st selective femoral coronography (1964)
• MHI specialists were the first to publish a description of the blockages that occur in grafts after an aortocoronary bypass, which helped to modify heart surgery techniques throughout the world (1972-1974)
• 1st percutaneous laser coronary dilatation (1987)
• 1st heart catheterization procedure using the new CROSSER technology on a child with a completely blocked heart artery, in collaboration with the Sainte-Justine UHC (2006)

 

 

Canadian Premieres achieved at the MHI:

 

• 1st hospital specializing in cardiology (1954)
• 1st cardiac procedure using an artificial heart-lung machine (1957)
• 1st heart transplant (1968
• 1st coronary angioplasty (1980
• 1st percutaneous aortic valvular dilatation (1986
• 1st mitral valve dilatation (1987
• 1st post-infarction percutaneous closure of an interventricular septal defect (2002)
• 1st combined treatment of an interventricular septal defect and a heart bypass (2003)
• 1st treatment of Kawasaki disease using the "Rotoblator" on a child collaboration with the Sainte-Justine UHC (2006)
• 1st implantation of a new type of aortic valve without open-heart surgery (2006 North-American first)
• 1st implantation of a new type of cardiac defibrillator with wireless remote monitoring capability (ConcertoTM) (2006)
• 1st atrial fibrillation treatment using cryoablation (2007)
• 1st optimal ultrafiltration using the new Aquadex FlexFlow ultrafiltration system (2008)

 

 

Dr. Jocelyn Dupuis

 

The originator of the PulmoBind concept and our Chief Medical Researcher, he has unrivalled experience and expertise in his chosen field.

 

Main areas of expertise:

 

• 17 years of research on the pulmonary circulation in health and disease
• Cardiology - Cardiovascular Diseases
• Physiology - Cardiopulmonary Physiology
• Pharmacology and Toxicology - Cardiovascular Pharmacology
• Molecular and Cellular Biology - Physiology, Cell
• Medical Sciences - Experimental Medicine

 

Work Experience:

 

• Cardiologist at the Montreal Heart Institute
• Associate Professor of Medicine, University of Montreal
• National Researcher of the Quebec Foundation for Health Research
• President of Pharmacology committee of the Montreal Heart Institute
• Editorial Consultant – Journal of the American College of Cardiology
• Editorial Board – Canadian Journal of Cardiology
• Member of the Scientific Program Committee of the Canadian Cardiovascular Society
• Past Member of the Scientific committee of the Quebec Heart and Stroke Foundation
• Past Member of the Junior II Scholarship committee of the Quebec Foundation for Health Research
• Former Director Coronary Care Unit Montreal Heart Institute

 

Academic Training:

 

• Doctor of Medicine – 1986 – University of Montreal
• Straight Medical Internship – 1987 – Royal Victoria Hospital Canada
• Doctorate (PhD) Experimental Medicine – 1990 – McGill University Canada
• Fellowship - Vasoactive Peptides Chemistry - 1990 - University of Miami, USA
• Fellowship – Internal Medicine- 1991- Sherbrooke University Canada
• Fellowship – Cardiology – 1993 – Sherbrooke Hospital Canada
• Postdoctoral Research Fellow – Pulmonary Metabolic Functions – 1994 – Montreal General Hospital
• Fellow of the Royal College of physicians and surgeons of Canada
• Fellow of the American college of Cardiology

 

Publications:

 

• Patents – 8 (1 granted, 7 in progress)
• 90 Papers published
• 5 contributions to a collective work
• 122 abstracts published
• 5 Books and Monographs
• 61 presentations as guest speaker

 

 

© 2011 Pulmo BioTech Incorporated